PMID: 16109547
Borthakur G, Tallman MS, Ofran Y, Foran J, Uy G, DiPersio J, Nagler A, Rowe J, Showel MM, Altman JK, Peled A, Abraham M, Pereg Y, Vainstein A, Oberkovitz G, Lustig TM, Brawer S, Bohana-Kashtan O, Cortes JE, Andreeff M
Menstrual cycle changes are reported by approximately 20 percent of female researchers, likely related to the hormonal shifts that accompany rapid weight loss rather than a direct effect of the medication
However, despite these improvements in redox balance, no significant recovery of behavioral deficits was observed, suggesting a heterogeneous relationship between molecular and functional outcomes
At Salt Boutique Labs, we specialize in using semaglutide to help patients with both type 2 diabetes and weight loss
Safety, Personalization, and Doctor Supervision When it comes to hormone-related therapies, safety and monitoring are paramount